Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Tyra Biosciences, Inc. | Other* | Common Stock | 4.45M | $125M | $28.16 | Oct 18, 2024 | Indirect |
Tango Therapeutics, Inc. | Other* | Common Stock | 3.61M | $11.3M | $3.14 | Nov 6, 2024 | Indirect |
Tyra Biosciences, Inc. | Other* | Pre-Funded Warrant (right to purchase) | 2.71M | Oct 18, 2024 | Indirect |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TNGX | Tango Therapeutics, Inc. | Nov 6, 2024 | 1 | -$9.67M | 4 | Nov 7, 2024 | Other* |
TNGX | Tango Therapeutics, Inc. | Oct 25, 2024 | 1 | -$4.35M | 4 | Oct 28, 2024 | Other* |
TNGX | Tango Therapeutics, Inc. | Oct 21, 2024 | 2 | -$6.1M | 4 | Oct 23, 2024 | Other* |
TYRA | Tyra Biosciences, Inc. | Oct 18, 2024 | 2 | $0 | 4 | Oct 22, 2024 | Other* |
TNGX | Tango Therapeutics, Inc. | Oct 10, 2024 | 0 | $0 | 3 | Oct 22, 2024 | Other* |
TYRA | Tyra Biosciences, Inc. | Oct 10, 2024 | 0 | $0 | 3 | Oct 22, 2024 | Other* |